Sign Up to like & get
recommendations!
1
Published in 2022 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2022.121623
Abstract: Impairment of oligodendrocyte progenitor cell (OPC) differentiation into oligodendrocytes and chronic inflammation are key determinants of poor remyelination observed in diseases such as multiple sclerosis. For many pro-myelinating molecules, the therapeutic potential is hindered by…
read more here.
Keywords:
pdgfr;
oligodendrocyte progenitor;
pdgfr antibody;
anti pdgfr ... See more keywords